ARLTS1 and Prostate Cancer Risk - Analysis of Expression and Regulation

• Sanna Siltanen,

  Affiliation Institute of Biomedical Technology/BioMediTech, University of Tampere and Fimlab Laboratories, Tampere, Finland

  ⨯
• Daniel Fischer,

  Affiliation School of Health Sciences, University of Tampere, Tampere, Finland

  ⨯
• Tommi Rantapero,

  Affiliation Institute of Biomedical Technology/BioMediTech, University of Tampere and Fimlab Laboratories, Tampere, Finland

  ⨯
• Virpi Laitinen,

  Affiliation Institute of Biomedical Technology/BioMediTech, University of Tampere and Fimlab Laboratories, Tampere, Finland

  ⨯
• John Patrick Mpindi,

  Affiliation Institute for Molecular Medicine (FIMM), University of Helsinki, Helsinki, Finland

  ⨯
• Olli Kallioniemi,

  Affiliation Institute for Molecular Medicine (FIMM), University of Helsinki, Helsinki, Finland

  ⨯
• Tiina Wahlfors,

  Affiliation Institute of Biomedical Technology/BioMediTech, University of Tampere and Fimlab Laboratories, Tampere, Finland

  ⨯
• Johanna Schleutker

  * E-mail: Johanna.Schleutker@utu.fi

  Affiliations Institute of Biomedical Technology/BioMediTech, University of Tampere and Fimlab Laboratories, Tampere, Finland, Department of Medical Biochemistry and Genetics, Institute of Biomedicine, University of Turku, Turku, Finland

  ⨯